微信小陈
微信小章
产品简介
购买须知
| 产品名称： | Proteus mirabilis Hauser |
|---|---|
| 商品货号： | TS162221 |
| Strain Designations： | Pm 631 |
| Application： | Produces beta-lactamase TEM-89 |
| Isolation： | Blood - human, blood culture from paraplegic and diabetic patient, University Hospital, Dijon, France, April 21, 2000 |
| Biosafety Level： | 2
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Product Format： | freeze-dried |
| Storage Conditions： | Frozen: -80°C or colder Freeze-Dried: 2°C to 8°C Live Culture: See Propagation Section |
| Preceptrol®： | no |
| Type Strain： | no |
| Medium： | ATCC® Medium 18: Trypticase Soy Agar/Broth |
| Growth Conditions： | Temperature: 37°C Atmosphere: Aerobic |
| Name of Depositor： | C Neuwirth |
| Special Collection： | NCRR Contract |
| Year of Origin： | 2000 |
| References： | Neuwirth C, et al. TEM-89 beta-lactamase produced by a Proteus mirabilis clinical isolate: new complex mutant (CMT 3) with mutations in both TEM-59 (IRT-17) and TEM-3. Antimicrob. Agents Chemother. 45: 3591-3594, 2001. PubMed: 11709345 |
| Cross References： | Nucleotide (GenBank) : AY039040 Proteus mirabilis TEM-89 beta-lactamase (TEM-89) gene, partial cds. |